Literature DB >> 26833940

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Chong Tin Tan1, Zhifeng Mao2, Wei Qiu2, Xueqiang Hu2, Dean M Wingerchuk3, Brian G Weinshenker4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26833940     DOI： 10.1212/WNL.0000000000002366

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  21 in total

1.  Diagnostic implications of MOG/AQP4 antibodies in recurrent optic neuritis.

Authors:  Ying Peng; Lei Liu; Yuanchu Zheng; Zhixin Qiao; Kai Feng; Jiawei Wang
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

Review 2.  Herpes zoster preceding neuromyelitis optica spectrum disorder: casual or causal relationship? A systematic literature review.

Authors:  Emanuela Claudia Turco; Erica Curti; Francesco Pisani; Franco Granella
Journal:  J Neurovirol       Date:  2022-04-24       Impact factor: 2.643

3.  Vision improvement in severe acute isolated optic neuritis after plasma exchange treatment in Chinese population: a prospective case series study.

Authors:  Shaoying Tan; Tsz Kin Ng; Quangang Xu; Mo Yang; Yuan Zhuang; Jie Zhao; Huanfen Zhou; Da Teng; Shihui Wei
Journal:  Ther Adv Neurol Disord       Date:  2020-08-21       Impact factor: 6.570

Review 4.  Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Authors:  Joseph Kuchling; Alexander U Brandt; Friedemann Paul; Michael Scheel
Journal:  EPMA J       Date:  2017-07-25       Impact factor: 6.543

Review 5.  Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review.

Authors:  Aigli G Vakrakou; Maria-Eleptheria Evangelopoulos; Georgios Boutzios; Dimitrios Tzanetakos; John Tzartos; Georgios Velonakis; Panagiotis Toulas; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Leonidas Stefanis; George E Fragoulis; Constantinos Kilidireas
Journal:  Rheumatol Int       Date:  2020-01-02       Impact factor: 2.631

6.  The Prevalence of Anti-Aquaporin 4 Antibody in Patients with Idiopathic Inflammatory Demyelinating Diseases Presented to a Tertiary Hospital in Malaysia: Presentation and Prognosis.

Authors:  S Abdullah; W F Wong; C T Tan
Journal:  Mult Scler Int       Date:  2017-01-19

7.  Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport.

Authors:  Simone Mader; Lior Brimberg; John N Soltys; Jeffrey L Bennett; Betty Diamond
Journal:  Front Immunol       Date:  2018-07-13       Impact factor: 7.561

8.  Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists.

Authors:  Shawheen J Rezaei; Andre C Vogel; Brittany Gazdag; Nicholas Alakel; Aditya Ravi Kumar; Farrah J Mateen
Journal:  J Neuroimmunol       Date:  2020-07-11       Impact factor: 3.478

9.  Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.

Authors:  Benedikt Grünewald; Jeffrey L Bennett; Klaus V Toyka; Claudia Sommer; Christian Geis
Journal:  Int J Mol Sci       Date:  2016-08-26       Impact factor: 5.923

10.  Anaplastic astrocytoma with aquaporin-4 positive in CSF: A case report.

Authors:  Yuanyuan Liu; Feng Gao; Hongjun Hao; Weiping Sun; Yining Huang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.